The treatment of breast cancer has been changing, and that includes chemotherapy, a range of drugs that can cause harsh side effects. It's a treatment that now is often minimized—or not used at all—for some patients.
Biomarkers could determine the need for chemotherapy in young patients with ER+ breast cancer < Yale School of Medicine
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
PDF) Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
Trastuzumab Deruxtecan for Metastatic HER2-Low Breast Cancer - NCI
Osmol Therapeutics, Inc. on LinkedIn: #amplifyherhealth #cipn #breastcancer #womenshealth
The Breast Cancer Book: A Trusted Guide for You and Your Loved Ones: Miller, Kenneth D., Camp, Melissa, Steligo, Kathy: 9781421441917: Hematology: Canada
Comprehensive Breast Cancer Care at Smilow Cancer Hospital in New Haven < Yale School of Medicine
Diagnosis of Princess Kate's Cancer Followed Familiar Pattern, Doctors Say - The New York Times
Do You Still Need Chemo for Breast Cancer? > News > Yale Medicine
Oncology Data Advisor - Understanding Antibody-Drug Conjugates for Treatment of Breast Cancer